Related references
Note: Only part of the references are listed.A retrospective analysis of ketamine intravenous therapy for depression in real-world care settings
L. Alison McInnes et al.
JOURNAL OF AFFECTIVE DISORDERS (2022)
Decreases in Suicidality Following Psychedelic Therapy: A Meta-Analysis of Individual Patient Data Across Clinical Trials
Richard J. Zeifman et al.
JOURNAL OF CLINICAL PSYCHIATRY (2022)
Mental Health Care Providers' Attitudes Toward Telepsychiatry: A Systemwide, Multisite Survey During the COVID-19 Pandemic
Daniel Guinart et al.
PSYCHIATRIC SERVICES (2021)
Trait dissociation as a predictor of induced dissociation by ketamine or esketamine in treatment-resistant depression: Secondary analysis from a randomized controlled trial*
Rodrig P. Mello et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2021)
Mental Health and Clinical Psychological Science in the Time of COVID-19: Challenges, Opportunities, and a Call to Action
June Gruber et al.
AMERICAN PSYCHOLOGIST (2021)
Changes in the global burden of depression from 1990 to 2017: Findings from the Global Burden of Disease study
Qingqing Liu et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2020)
Psychedelics and Psychedelic-Assisted Psychotherapy
Collin M. Reiff et al.
AMERICAN JOURNAL OF PSYCHIATRY (2020)
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
Maurizio Fava et al.
MOLECULAR PSYCHIATRY (2020)
Defining Success in Measurement-Based Care for Depression: A Comparison of Common Metrics
R. Yates Coley et al.
PSYCHIATRIC SERVICES (2020)
Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials
Joanna Kryst et al.
PHARMACOLOGICAL REPORTS (2020)
Two-way messaging therapy for depression and anxiety: longitudinal response trajectories
Thomas D. Hull et al.
BMC PSYCHIATRY (2020)
Sublingual Ketamine: An Option for Increasing Accessibility of Ketamine Treatments for Depression?
Jennifer Swainson et al.
JOURNAL OF CLINICAL PSYCHIATRY (2020)
Association of Mental Health Disorders With Health Care Spending in the Medicare Population
Jose F. Figueroa et al.
JAMA NETWORK OPEN (2020)
Patients with major depressive disorder have lower cerebral serotonin 4 receptor binding than healthy controls
K. Koehler-Forsberg et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Leveraging Neuroplasticity to Enhance Adaptive Learning: The Potential for Synergistic Somatic-Behavioral Treatment Combinations to Improve Clinical Outcomes in Depression
Samuel T. Wilkinson et al.
BIOLOGICAL PSYCHIATRY (2019)
The fear of needles: A systematic review and meta-analysis
Jennifer McLenon et al.
JOURNAL OF ADVANCED NURSING (2019)
Anxiety during ketamine infusions is associated with negative treatment responses in major depressive disorder
Sabine Aust et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2019)
The digital revolution and its impact on mental health care
Sandra Bucci et al.
PSYCHOLOGY AND PSYCHOTHERAPY-THEORY RESEARCH AND PRACTICE (2019)
Effectiveness and Acceptability of Cognitive Behavior Therapy Delivery Formats in Adults With Depression: A Network Meta-analysis
Pim Cuijpers et al.
JAMA PSYCHIATRY (2019)
Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial
Jennifer L. Phillips et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression
Mark J. Niciu et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Safety and efficacy of maintenance ketamine treatment in patients with treatment-refractory generalised anxiety and social anxiety disorders
Paul Glue et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
Measuring and improving the quality of mental health care: a global perspective
Amy M. Kilbourne et al.
WORLD PSYCHIATRY (2018)
Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development
Eduardo Ekman Schenberg
FRONTIERS IN PHARMACOLOGY (2018)
The Lancet Psychiatry Commission on psychological treatments research in tomorrow's science
Emily A. Holmes et al.
LANCET PSYCHIATRY (2018)
Side-effects associated with ketamine use in depression: a systematic review
Brooke Short et al.
LANCET PSYCHIATRY (2018)
The first 30 months of the MindSpot Clinic: Evaluation of a national e-mental health service against project objectives
Nickolai Titov et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2017)
Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion
Steven J. Pennybaker et al.
JOURNAL OF AFFECTIVE DISORDERS (2017)
The Effect of Cognitive-Behavioral Therapy as an Antidepressive Treatment Is Falling: Reply to Ljotsson et al. (2017) and Cristea et al. (2017)
Oddgeir Friborg et al.
PSYCHOLOGICAL BULLETIN (2017)
Cognitive Behavior Therapy May Sustain Antidepressant Effects of Intravenous Ketamine in Treatment-Resistant Depression
Samuel T. Wilkinson et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2017)
A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders
Gerard Sanacora et al.
JAMA PSYCHIATRY (2017)
Technology-Enhanced Human Interaction in Psychotherapy
Zac E. Imel et al.
JOURNAL OF COUNSELING PSYCHOLOGY (2017)
Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression
Marc S. Lener et al.
DRUGS (2017)
Ketamine as a novel treatment for major depressive disorder and bipolar depression: a systematic review and quantitative meta-analysis
Ellen E. Lee et al.
GENERAL HOSPITAL PSYCHIATRY (2015)
The Effects of Cognitive Behavioral Therapy as an Anti-Depressive Treatment is Falling: A Meta-Analysis
Tom J. Johnsen et al.
PSYCHOLOGICAL BULLETIN (2015)
Psychometric and diagnostic properties of the Drug Abuse Screening Test (DAST): Comparing the DAST-20 vs. the DAST-10
Luis Villalobos-Gallegos et al.
SALUD MENTAL (2015)
Frequency of reporting of adverse events in randomized controlled trials of psychotherapy vs. psychopharmacotherapy
Barney Vaughan et al.
COMPREHENSIVE PSYCHIATRY (2014)
Do the dissociative side effects of ketamine mediate its antidepressant effects?
David A. Luckenbaugh et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
Clinical Predictors of Ketamine Response in Treatment-Resistant Major Depression
Mark J. Niciu et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
Ketamine as a new treatment for depression: A review of its efficacy and adverse effects
Natalie Katalinic et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2013)
Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression
Diogo R. Lara et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
MissForest-non-parametric missing value imputation for mixed-type data
Daniel J. Stekhoven et al.
BIOINFORMATICS (2012)
Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States
Ronald C. Kessler et al.
INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH (2012)
The Columbia-Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults
Kelly Posner et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [1H]-MRS
Gerald W. Valentine et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2011)
Barriers to mental health treatment: results from the National Comorbidity Survey Replication
R. Mojtabai et al.
PSYCHOLOGICAL MEDICINE (2011)
Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
Marije aan het Rot et al.
BIOLOGICAL PSYCHIATRY (2010)
Antidepressant Drug Effects and Depression Severity A Patient-Level Meta-analysis
Jay C. Fournier et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
WHAT DO PSYCHOTHERAPISTS REALLY DO IN PRACTICE? AN INTERNET STUDY OF OVER 2,000 PRACTITIONERS
Joan M. Cook et al.
PSYCHOTHERAPY (2010)
Development of a Sublingual/Oral Formulation of Ketamine for Use in Neuropathic Pain Preliminary Findings from a Three-Way Randomized, Crossover Study
Chui Chong et al.
CLINICAL DRUG INVESTIGATION (2009)
Mental health in the context of health disparities
Jeanne Miranda et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Anxiety disorders in primary care:: Prevalence, impairment, comorbidity, and detection
Kurt Kroenke et al.
ANNALS OF INTERNAL MEDICINE (2007)
Deciding on the number of classes in latent class analysis and growth mixture modeling: A Monte Carlo simulation study
Karen L. Nylund et al.
STRUCTURAL EQUATION MODELING-A MULTIDISCIPLINARY JOURNAL (2007)
Single versus repeated sessions of ketamine-assisted psychotherapy for people with heroin dependence
Evgeny M. Krupitsky et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2007)
A brief measure for assessing generalized anxiety disorder -: The GAD-7
Robert L. Spitzer et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice
MH Trivedi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Barriers to psychotherapy among depressed and nondepressed primary care patients
David. C. Mohr et al.
ANNALS OF BEHAVIORAL MEDICINE (2006)
Plasma concentration profiles of ketamine and norketamine after administration of various ketamine preparations to healthy Japanese volunteers
Y Yanagihara et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2003)
The PHQ-9: A new depression diagnostic and severity measure
K Kroenke et al.
PSYCHIATRIC ANNALS (2002)
Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care - A randomized trial
K Kroenke et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
The PHQ-9 - Validity of a brief depression severity measure
K Kroenke et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2001)
Share Paper
